Haleon PLC
HLN8.820USD
+0.110+1.26%
收盤 09/26, 16:00（美東）報價延遲15分鐘
79.24B總市值
54.95本益比TTM
關於 Haleon PLC 公司
Haleon plc 是一家消費者保健公司。該公司的產品組合包括五大類別，包括口腔健康、維生素、礦物質和補充劑 (VMS)、疼痛緩解、呼吸健康、消化健康和其他。該公司的地理分部包括北美、歐洲、中東、非洲和拉丁美洲 (EMEA 和 LatAm) 以及亞太地區 (APAC)。其呼吸健康品牌爲一系列呼吸問題提供產品解決方案，包括感冒和流感、鼻塞、咳嗽和過敏。該公司的消化健康和其他產品還包括皮膚健康和吸菸者健康。其口腔健康品牌包括 Sensodyne、Polident、Parodontax 和 Biotene。其 VMS 品牌包括 Centrum、Emergen-C 和 Caltrate。其呼吸品牌包括 Otrivin、Theraflu 和 Flonase。其疼痛緩解品牌包括 Voltaren、Panadol 和 Advil。其消化健康品牌包括 TUMS、ENO 和 Fenistil。
公司簡介
公司代碼HLN
公司名稱Haleon PLC
上市日期Jul 18, 2022
CEOMr. Brian Mcnamara
員工數量- -
證券類型Ordinary Share
年結日Jul 18
公司地址Building 5, First Floor
城市WEYBRIDGE
上市交易所London Stock Exchange
國家United Kingdom
郵編KT13 0NY
電話441932822000
網址https://www.haleon.com/
公司代碼HLN
上市日期Jul 18, 2022
CEOMr. Brian Mcnamara
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
444.67K
+0.83%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ed Petter
Mr. Ed Petter
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
444.67K
+0.83%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
收入明細
單位: GBP更新時間: 7月6日 週日
單位: GBP更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務GBP
名稱
營收
佔比
Oral health
880.00M
30.84%
Pain relief
661.00M
23.17%
Respiratory health
465.00M
16.30%
Digestive health and other
431.00M
15.11%
Vitamins, minerals and supplements
416.00M
14.58%
地區GBP
名稱
營收
佔比
EMEA and LatAm
1.19B
41.64%
Northern America
980.00M
34.35%
APAC
685.00M
24.01%
業務
地區
業務GBP
名稱
營收
佔比
Oral health
880.00M
30.84%
Pain relief
661.00M
23.17%
Respiratory health
465.00M
16.30%
Digestive health and other
431.00M
15.11%
Vitamins, minerals and supplements
416.00M
14.58%
股東統計
更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
其他
92.79%
持股股東
持股股東
佔比
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
其他
92.79%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
5.75%
Investment Advisor
5.42%
Hedge Fund
0.78%
Research Firm
0.65%
Bank and Trust
0.17%
Family Office
0.07%
Family Office
0.06%
Family Office
0.06%
Individual Investor
0.02%
其他
87.02%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
2023Q2
891
677.74M
14.68%
-44.11M
2023Q1
842
667.68M
14.46%
-14.30M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Dodge & Cox
169.15M
3.77%
-9.59M
-5.37%
Mar 31, 2025
Fidelity Management & Research Company LLC
97.16M
2.16%
+2.47M
+2.61%
Mar 31, 2025
ClearBridge Investments, LLC
32.59M
0.73%
-208.31K
-0.64%
Mar 31, 2025
Harding Loevner LP
23.07M
0.51%
-1.05M
-4.37%
Mar 31, 2025
Fidelity Institutional Asset Management
14.29M
0.32%
+153.75K
+1.09%
Mar 31, 2025
Wellington Management Company, LLP
18.70M
0.42%
+3.37M
+22.00%
Mar 31, 2025
Managed Account Advisors LLC
4.84M
0.11%
+129.49K
+2.75%
Mar 31, 2025
Sculptor Capital Management, Inc
10.85M
0.24%
+1.96M
+22.09%
Mar 31, 2025
Aristotle Capital Management, LLC
8.44M
0.19%
-314.11K
-3.59%
Mar 31, 2025
Parametric Portfolio Associates LLC
7.67M
0.17%
+569.43K
+8.02%
Mar 31, 2025
查看更多
持股ETF
更新時間: 9月6日 週六
更新時間: 9月6日 週六
機構名稱
佔比
VanEck Pharmaceutical ETF
4.79%
GMO International Quality ETF
4.23%
Franklin ClearBridge Enhanced Income ETF
1.88%
Rockefeller Global Equity ETF
1.17%
One Global ETF
0.78%
ActivePassive International Equity ETF
0.36%
SP Funds S&P World (ex-US) ETF
0.28%
Avantis International Equity ETF
0.1%
Avantis Responsible International Equity ETF
0.09%
Avantis International Large Cap Value ETF
0%
查看更多
VanEck Pharmaceutical ETF
佔比4.79%
GMO International Quality ETF
佔比4.23%
Franklin ClearBridge Enhanced Income ETF
佔比1.88%
Rockefeller Global Equity ETF
佔比1.17%
One Global ETF
佔比0.78%
ActivePassive International Equity ETF
佔比0.36%
SP Funds S&P World (ex-US) ETF
佔比0.28%
Avantis International Equity ETF
佔比0.1%
Avantis Responsible International Equity ETF
佔比0.09%
Avantis International Large Cap Value ETF
佔比0%
分紅派息
近5年累計派現
570.00M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
